longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

ClinPlus has established a new pharmaceutical technology company in Chengdu

Zhitong
Jun 23, 2025 at 06:31 AM

According to the Qichacha APP, recently, Rongxin Zhiyuan Medical Technology Co., Ltd. was established, with Wei Li as the legal representative. The business scope includes: medical research and experimental development; second-class value-added telecommunications services, etc. Qichacha's equity penetration shows that the company is wholly owned by ClinPlus

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Sep 9, 2026 at 11:04 AMWith AMZN on board, is QCOM's AI second S-curve locked in?
ClinPlus

ClinPlus

301257.SZ

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI